GSTM5 inhibitors represent a class of chemical compounds characterized by their ability to selectively target and modulate the activity of the enzyme Glutathione S-Transferase Mu 5 (GSTM5). GSTM5 is a member of the glutathione S-transferase (GST) family of enzymes, which play a crucial role in cellular detoxification and the metabolism of various xenobiotics and endogenous compounds. These inhibitors are designed to interfere with the catalytic activity of GSTM5, leading to the disruption of its enzymatic function.The mechanisms of action employed by GSTM5 inhibitors vary but generally involve interactions with the enzyme's active site. Many of these inhibitors, such as Auranofin and Ethacrynic Acid, form covalent bonds with key amino acid residues within the active site of GSTM5, rendering the enzyme inactive.
This inhibition prevents GSTM5 from catalyzing reactions that involve the conjugation of glutathione with electrophilic compounds, an essential step in detoxification processes. Other compounds, like Quercetin, competitively bind to the active site, thereby blocking substrates from accessing the catalytic site. Additionally, some GSTM5 inhibitors may act indirectly by modulating gene expression, leading to the downregulation of GSTM5 levels within cells.This class of compounds is of significant interest in research related to understanding cellular processes, especially those involved in detoxification and drug metabolism. GSTM5 inhibitors serve as valuable tools for dissecting the specific roles of GSTM5 in these processes and can contribute to a deeper understanding of the biochemistry of cellular detoxification pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin inhibits GSTM5 by forming a complex with glutathione, disrupting its binding to the enzyme's active site, thus inhibiting its activity. | ||||||
Ethacrynic acid | 58-54-8 | sc-257424 sc-257424A | 1 g 5 g | $90.00 $300.00 | 5 | |
Ethacrynic acid covalently modifies GSTM5 by forming a thiol-reactive conjugate, rendering the enzyme inactive. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine inhibits GSTM5 by binding to its active site, preventing the enzyme from catalyzing glutathione conjugation reactions. | ||||||
Clioquinol | 130-26-7 | sc-201066 sc-201066A | 1 g 5 g | $45.00 $115.00 | 2 | |
Clioquinol inhibits GSTM5 through a yet not fully understood mechanism that disrupts its catalytic activity. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid inhibits GSTM5 by binding to the enzyme's active site, preventing its catalytic activity. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits GSTM5 through competitive inhibition, competing with substrates for binding to the enzyme's active site. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin inhibits GSTM5 by binding to its active site, blocking its ability to catalyze glutathione conjugation reactions. | ||||||
Naproxen | 22204-53-1 | sc-200506 sc-200506A | 1 g 5 g | $24.00 $41.00 | ||
Naproxen inhibits GSTM5 by competitively binding to its active site, interfering with its catalytic function. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen inhibits GSTM5 through competitive binding to its active site, preventing its glutathione conjugation activity. | ||||||